Abstract
HIV infection and AIDS are having a major and growing impact on women’s lives. In addition to the usually described risk behaviors, many other medical or behavioral factors should prompt physicians to offer HIV counseling and testing. These include unusual or difficult-to-treat gynecologic conditions, unexplained vague systemic symptoms, and most sexually transmitted diseases. Use of alcohol and crack cocaine can be associated with a higher risk of HIV infection because of decreased risk reduction behaviors. The authors discuss the barriers to risk reduction among women deriving from their unequal social roles in relation to men and provide specific and detailed guidelines for counseling and educating women about HIV infection.
Similar content being viewed by others
References
Summary of vital statistics, 1988. New York: Bureau of Health Statistics and Analysis. New York City Department of Health, 1989.
Chu S, Buehler J, Berkelman L. Impact of the HIV epidemic on mortality in women of reproductive age. JAMA. 1990;264:225–9.
Norwood C. Women and the hidden AIDS epidemic. Network News-Newsletter of the National Women’s Health Network. 1988;(Nov/Dec):1, 6.
Hoegsberg B, Dotson T, Minkoff H. Human immunodeficiency virus in women with pelvic inflammatory disease [abstracts]. Stockholm, Sweden: Fourth International Conference on AIDS, 1988;1:333.
Rhoads J, Wright D, Redfield R, et al. Chronic vaginal candidasis in women with human immunodeficiency virus infection. JAMA. 1987;257:3105–7.
Provenchar D, Valme B, Averette H, et al. HIV status and positive papanicolaou screening: Identification of a high risk population. Gynecol Oncol. 1988;31:184–90.
Schrager L, Friedland G, Maude D, et al. Cervical and vaginal squamous cell abnormalities in women infected with human immunodeficiency virus. J Acquir Immune Defic Synd. 1989;2:570–5.
Feingold A, Vermund S, Burk R, et al. Cervical cytologic abnormalities and papillomavirus in women infected with human immunodeficiency virus. J Acquir Immune Defic Synd. 1990;3:896–903.
Centers for Disease Control. HIV/AIDS surveillance report, 1990;Sep:1–18.
St. Louis M, Rauch K, Peterson L, et al. Sero prevalence rates of human immunodeficiency virus infection at Sentinel Hospitals in the United States. N Engl J Med. 1990;323:213–8.
Ward J, Kleinman S, Douglas D. Epidemiologic characteristics of blood donors with antibody to human immunodeficiency virus. Transfusion. 1988;28:298–301.
Checola R, Hand I, Wiznia A, et al. Maternal drug abuse and perinatal HIV sero positivity [abstract]. In: Proceedings of the fifth International Conference on AIDS. Ottawa, Ontario: International Development Research Centre, 1989;313.
Landesman S, Minkoff H, Holman S, et al. Serosurvey of human immunodeficiency virus infection in parturients. JAMA. 1987;258:2701–3.
Goldsmith M, Sex tied to drugs = STD spread. JAMA. 1988;260:2009.
Marte C, Cohen M, Fruchter R. Pap test and STD findings in HIV-positive women at ambulatory care sites. In: Proceedings of the sixth International Conference on AIDS. San Francisco: Moscone Center, 1990;2:210.
Tempelis C, Chandler A, Benjamin R. HIV-I seroprevalence in STD clinic patients in a county in the San Francisco Bay area. In: Proceedings of the sixth International Conference on AIDS. San Francisco: Moscone Center, 1990;2:222.
Carael M, Vandeperre P, Lepage P. Risk factors for HIV among heterosexual couples in central Africa. In: Proceedings of the fourth International Conference on AIDS. Stockholm, Sweden: 1988;1:261.
Rautenberg E, Weisfuse I. Using seroprevalence and immunologic data to estimate ambulatory, laboratory and pharmaceutical needs of a largely asymptomatic population. In: Proceedings of the sixth International Conference on AIDS. San Francisco: Moscone Center, 1990;1:316.
Ellis B, Cox K, Federspiel C. Underreporting risk behaviors for HIV infection among STD clinic patients: case control study of coincident morbidity. In: Proceedings of the sxith International Conference on AIDS. San Francisco: Moscone Center, 1990;2:263.
Greenberg B, Weisfuse I, Back S, et al. HIV seroprevalence in patients attending New York City Department of Health tuberculosis clinics. In: Proceedings of the sixth International Conference on AIDS. San Francisco: Moscone Center, 1990;1:306.
Castro K, Metchock B, McGowan J, et al. Association between mycobacterial cultures and HIV infection in a large municipal hospital. In: Proceedings of the sixth International Conference on AIDS. San Francisco: Moscone Center, 1990;1:306.
Rehmet S, Staszewski S, Von Wangenheim I, et al. HIV transmission rates and co-factors in heterosexual couples. In: Proceedings of the sixth International Conference on AIDS. San Francisco: Moscone Center, 1990;1:270.
Klemetson D, Moss G, D’Costa L. Incidence of HIV transmission within HIV-1 discordant heterosexual partnerships in Nairobi, Kenya. In: Proceedings of the sixth International Conference on AIDS. San Francisco: Moscone Center, 1990;2:448.
Mays V, Cochran S. Issues in the perception of AIDS risk and risk reduction activity by black and Hispanic/Latina women. Am Psychol. 1988;43:949–57.
Centers for Disease Control. Recommendations for assisting in the prevention of perinatal transmission of human T-lymphotrophic virus type III/lymphadenopathy-associated virus and acquired immunodeficiency syndrome. MMWR. 1985;34:725.
Chavkin W. Drug addiction and pregnancy: policy crossroads. Am J Public Health. 1990;4:483–7.
New York City Department of Health. A woman’s guide to AIDS. New York: New York City Department of Health, 1989.
Shiflett S, Mantell J, Drayton M, et al. Ethnic differences in AIDS knowledge as a function of personal and situational factors among inner-city women of childbearing age. Oral presentation, 117th annual meeting of the American Public Health Association. New York: American Public Health Association, 1990.
Anastos K, Marte C. Women-the missing persons in the AIDS epidemic. Health/PAC bulletin. 1989;19:6–13.
Marte C, Anastos K. Women, AIDS, and reproductive rights: women—the missing persons in the AIDS epidemic, part II. Health/PAC bulletin. 1990;20:11–8.
Chavkin W. Women, AIDS and reproductive rights: preventing AIDS, targeting women. Health/PAC bulletin. 1990;20:19–23.
Fischl M, Richmond D, Grieco M, et al. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex: a double-blind placebo controlled trial. N Engl J Med. 1987;317:185–91.
Volberding P, Lagakos S, Koch M, et al. Zidovudine in asymptomatic human immunodeficiency virus infection. N Engl J Med. 1990;322:941–9.
Centers for Disease Control. Guidelines for prophylaxis againstpneumocystis carinii pneumonia for persons infected with human immunodeficiency virus. MMWR. 1989;38(suppl 5):1–9.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Anastos, K., Palleja, S.M. Caring for women at risk of HIV infection. J Gen Intern Med 6 (Suppl 1), S40–S46 (1991). https://doi.org/10.1007/BF02599257
Issue Date:
DOI: https://doi.org/10.1007/BF02599257